From 2008 to 2019, the company’s revenue grew 225 percent and its U.S. surgical case volumes increased 184 percent.
The musculoskeletal implant development and commercialization company has reported positive organic growth for 13 consecutive years.
More articles on devices:
DePuy Synthes holds 19% of minor orthopedic device market – 3 takeaways
Globus Medical builds on 15 years of expandable devices with Fortify VA: 4 notes
UC San Diego Health purchases Mazor X robot for spine surgery: 4 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
